The Myc proto-oncogene has been intensively studied in tumorigenesis and development. A new paper in Cell reports the role of Myc as a determinant of mammalian longevity. Myc heterozygous mice exhibit extended lifespans resulting from alterations in multiple cellular processes distinct from those observed in other longevity models.
Myc ranks among the most exhaustively studied genes in the vertebrate genome. The intense interest stems from its essential and multiple roles in development and its critical functions in the etiology of most, if not all, cancers. The Myc protein is thought to function predominantly as a transcriptional regulator influencing the expression of thousands of genes and broadly promoting the fundamental cellular processes of growth, metabolism, proliferation, differentiation, and death in a context-dependent manner (for reviews, see Dang and Eisenman, 2014) . While Myc has been intensively studied at the cellular level, relatively little is known concerning its roles in organismal physiology. In this issue of Cell, Sedivy and coworkers (Hofmann et al., 2015) provide compelling evidence that mammalian longevity and healthspan are linked in multiple ways to the abundance of the Myc protein.
By comparing wild-type mice (Myc +/+ ) with mice expressing roughly half the amount of Myc mRNA and protein (Myc +/À ), Hofmann et al. found a 15% increase in median lifespan (combined for both sexes) caused by Myc hypomorphism. Importantly, the attenuated mortality is manifested across all ages, indicating that the impact of lowered Myc levels is not restricted to a specific period of time. This augmentation in lifespan appears to be accompanied by a diverse group of phenotypes that are indicative of an increased healthspan and correlate with other long-lived mouse models, such as calorie restricted (CR) and Ames dwarf mice (Gems and Partridge, 2013) . These phenotypes include decreases in body size, serum IGF1 levels, immunosenescence, spontaneous tumor progression, osteoporosis, and serum and liver cholesterol content, as well as enhanced metabolic rate and neuromuscular performance, all of which are characteristic of young animals and are observed in older Myc hypomorphic mice. While phenotypic similarities between Myc +/À and other lifespan-extending conditions are apparent, there are also some significant differences. For example, in the Myc hypomorphic mice, no changes are detected in body temperature, adiposity, or fertility, while all three are changed in other mouse models of increased longevity. Moreover, meta-analyses of gene expression profiles derived from mice with extended lifespan due to CR or metformin treatment reveal only few changes in common with those from the Myc hypomorphic mice. Together, these data suggest that lower Myc levels promote lifespan extension through a unique constellation of molecular events. In addition, as the authors point out, major consequences of decreased Myc may be indirect and not necessarily apparent at the transcriptional level. For instance, diminished rates of translation or suppression of mTOR activity have been linked to lifespan extension in flies, yeast, and nematodes (Gems and Partridge, 2013) . Previous studies in Drosophila melanogaster have implicated members of the Myc transcriptional network in the regulation of aging. Loss-of-function alleles of the Drosophila Myc antagonist, dMnt, increase cell size and body weight while decreasing fly lifespan (Loo et al., 2005) . More recently, Drosophila Myc has been shown to act as a rheostat for longevity, as its overexpression diminishes and heterozygous deletion augments longevity in flies (Greer et al., 2013) . These phenotypes appear to be independent of apoptosis and correlated with dMyc-induced genomic instability. In the Myc +/À mice, while apoptosis also appears unaffected, markers of DNA damage and senescence are unchanged and cells derived from these mice are equally sensitive to toxic chemicals compared to the wild-type controls, suggesting that the increased longevity and healthspan of the Myc hypomorphic mice are not likely to be due to resistance to genomic instability, oxidative stress, or cellular insults. However, it is yet to be determined whether the increased healthspan and lifespan could be due to a decreased frequency of insult. Potential candidates for driving the longevity phenotype include diminished serum IGF1 levels and increased metabolic rate, which are shared by Myc +/À mice and the somatotropic mutant mouse strains, such as the Ames dwarf mice, and the CR mice (Lee and Longo, 2011) . Importantly, IGF1 regulates mTOR activity via the PI3K-AKT pathway, and Myc +/À mice exhibit decreased IGF1 and mTOR activity, as well as decreased rRNA production and translation rate. In summary, these mice appear to display better proteostasis. Consistent with these findings, treatment with the mTOR inhibitor rapamycin or haploinsufficiency of mTOR components or targets has been shown to lead to increased lifespan (Johnson et al., 2013) .
Alterations in metabolism, as evidenced by enhanced oxygen-consumption and mitochondrial content and function, have also been associated with longevity. In Drosophila, expression of the PGC-1 transcriptional coactivator in intestinal stem cells (ISCs) results in stimulation of mitochondrial biogenesis and oxidative phosphorylation, which limits ISC proliferation and misdifferentiation, attenuates an age-dependent loss of tissue homeostasis, and promotes maintenance of a functional stem cell population characteristic of younger organisms (Rera et al., 2011) . Thus, metabolic changes may help to maintain tissue integrity by imposing a differentiation pace that does not deplete somatic quiescent stem cells. It has been well established that Myc exerts a profound effect on metabolic activity and mitochondrial function and regulates the size of stem, progenitor, and differentiated cell compartments (Dang and Eisenman, 2014; Freije et al., 2014; Laurenti et al., 2008) . Indeed, Hofmann et al. detect a higher ratio of quiescent long-term to proliferative short-term hematopoietic stem cells in Myc hypomorphic mice. This finding suggests that the loss of one Myc allele might be sufficient to limit the maximal abundance of Myc protein attained during stem and progenitor cell proliferation and differentiation, thereby dampening stem cell depletion, curtailing progenitor cell overgrowth, and positively affecting homeostasis of multiple cell lineages (Figure 1) .
Like most important findings, the work of Hofmann et al. on Myc's role in longevity raises more questions than it answers. One outstanding question concerns the tissues that are most directly relevant to longevity in the Myc hypomorphic mice. Is the longevity phenotype due to changes in multiple tissue types, or does one tissue predominate by triggering a cascade of events that ultimately extends both lifespan and healthspan? In particular, do nervous system-specific changes that lead to increased neuromuscular fitness and metabolic alterations contribute to better healthspan? Is the observed decrease in translation rate sufficient to account for the decrease in cholesterol biosynthetic enzymes and the lower production of IGF1 in the liver and serum? Could enhanced proteostasis resulting from diminished translational stress affect every tissue where protein quality control is important? Another interesting question is whether other members of the extended Myc network also play a role in regulating aging. It is evident that the more we know about even such a well-studied gene as Myc, the more we have to learn. 
